Received: 15 October 2020
Accepted: 20 April 2021
First Online: 30 April 2021
: By the Ethics Committee of Erasme hospital, free University of Brussels, (committee’s reference number P2020/031) on February 10th, 2020. No Consent to participate needed for a retrospective study.
: Not applicable.
: Alexandre Joosten is consultants for Edwards Lifesciences (Irvine, California, USA), for Aguettant Laboratoire (Lyon, France) and for Fresenius Kabi (Bad Homburg, Germany)Matthieu Legrand received research support from Shingotec (Hennigsdorf, Germany), lectures fees from Baxter (Guyancourt, France) and Fresenius Kabi (Bad Homburg, Germany), consulting fees from Novartis (Bâle, Switzerland)Philippe Van der Linden, has received, within the past 5 years, fees for lectures and consultancies from Fresenius GmbH (Bad Homburg, Germany), Aguettant SA (Lyon, France) and Nordic Pharma (Antwerpen, Belgium).Jean-Louis Vincent is Editor-in-Chief of Critical Care. He has no other conflicts related to this article.The other authors have no conflicts of interest related to this article.